Prognostic role of cardiac troponin I after percutaneous coronary intervention in stable coronary disease

Heart

Volumn 91, Issue 9, 2005, Pages 1181-1185

  Nageh, Thuria ^a   Sherwood, R A ^a   Harris, B M ^a   Thomas, M R ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN I;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; Q WAVE; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CORONARY DISEASE; CORONARY RESTENOSIS; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; TREATMENT OUTCOME; TROPONIN I;

EID: 23944527337     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2004.042911     Document Type: Article

References (27)

1. Abdelmeguid AE, Topol EJ, Whitlow PL, et al. Significance of mild transient release of creatine kinase-MB fractions after percutaneous coronary interventions. Circulation 1996;94:1528-36.
2. Tardiff BE, Califf RM, Tcheng JE, for the IMPACT-II Investigators, et al. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. J Am Coll Cardiol 1999;33:88-96.
3. Simoons ML, van der Brand M, Lincoff M, et al. Minimal myocardial damage during coronary intervention is associated with impaired outcome. Eur Heart J 1999;20:1112-9.
4. Wu AHB, Feng Y-J, Moore, et al for the American Association for Clinical Chemistry Subcommittee on cardiac troponin I standardization. Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparisons of assays for troponin T and I. Clin Chem 1998;44:1198-208.
5. Zimmerman J, Fromm R, Meyer D, et al. Diagnostic marker co-operative study for the diagnosis of myocardial infarction. Circulation 1999;99:1671-7.
6. Lindahl B, Venge P, Wallentin L, for the FRISC Study Group. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation 1996;93:1651-7.
7. Antman EM, Milanko J, Tanasijevic MJ, et al. Cardiac specific troponin I level to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996;336:1342-9.
8. Ohman ME, Armstrong PW, Christensen RH, for the GUSTO IIa Investigators, et al. Cardiac troponin T levels for risk stratification in acute myocardial ischaemia. N Engl J Med 1996;335:1333-41.
9. Luscher MS, Thygesen K, Ravkilde J, for the TRIM Study Group, et al. Applicability of cardiac troponin T and I for early risk stratification in unstable coronary disease. Circulation 1997;96:2578-85.
10. Galvani M, Ottani F, Ferrini D, et al. Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina. Circulation 1997;95:2053-9.
11. Kizer JR, Muttraj MR, Matthei WH, et al. Role of cardiac troponin T in the long term risk stratification of patients undergoing percutaneous coronary intervention. Eur Heart J 2003;24:1314-22.
12. Fuchs S, Kornowski R, Mehran R, et al. Prognostic value of cardiac troponin I levels following catheter-based coronary interventions. Am J Cardiol 2000;85:1077-82.
13. Matetzky S, Sharir T, Domingo M, et al. Elevated troponin I levels on admission is associated with adverse outcome of primary angioplasty in acute myocardial infarction. Circulation 2000;102:1611-6.
14. Cantor WJ, Newby LK, Christenson RH, et al. Prognostic significance of elevated troponin I after percutaneous coronary intervention. J Am Coll Cardiol 2002;39:1738-44.
15. Nageh T, Sherwood RA, Harris BM, et al. Cardiac troponin I for risk stratification following percutaneous coronary intervention in acute coronary syndrome. Cathet Cardiovasc Interv 2002;55:37-42.
16. Anon. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina. J Am Coll Cardiol 1999;33:2092-197.
17. Abdelmeguid AE, Whitlow PL, Sapp SK, et al. Long term outcome of transient uncomplicated in-lab coronary artery closure. Circulation 1995;91:2733-41.
18. Piana RN, Ahmed WH, Chaitman B, on behalf of the HIRULOG Angioplasty Study Investigators, et al. Effect of transient abrupt vessel closure during otherwise successful angioplasty for unstable angina on clinical outcome at six months. J Am Coll Cardiol 1999;33:73-8.
19. Tan K, Sulke N, Taub N, et al. Clinical and lesion morphologic determinants of coronary angioplasty success and complications: current experience. J Am Coll Cardiol 1995;25:855-65.
20. Lindahl B, Diderholm E, Lagerqvist B, et al. Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy. J Am Coll Cardiol 2001;38:979-86.
21. Riccardi MJ, Davidson O, Gubernikoff G, et al. Troponin I elevation and cardiac events after percutaneous coronary intervention. Am Heart J 2003;145:522-8.
22. Buffon A, Biasucci LM, Liuzzo G, et al. Widespread coronary inflammation in unstable angina. N Engl J Med 2002;347:5-12.
23. Kini A, Marmur JD, Kini S, et al. Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course. J Am Coll Cardiol 1999;34:663-71.
24. Walter DH, Fichtlscherer S, Britten MB, et al. Statin therapy, inflammation and recurrent coronary events in patients following stent implantation. J Am Coll Cardiol 2001;38:2006-12.
25. The EPISTENT Investigators. Evaluation of platelet IIb/IIIa inhibitors for stenting: randomized placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb/IIIa blockade. Lancet 1998;352:87-92.
26. The ESPRIT Investigators. Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomized, placebo controlled trial. Lancet 2000;356:2037-44.
27. Mehta SR, Yusuf S, Peters RJG, et al. Effects of pre-treatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary interventions: the PCI-CURE study. Lancet 2001;358:527-33.